Diazepam Binding Inhibitor anticorps (C-Term)
Aperçu rapide pour Diazepam Binding Inhibitor anticorps (C-Term) (ABIN7184541)
Antigène
Voir toutes Diazepam Binding Inhibitor (DBI) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Fonction
- DBI Antibody
-
Réactivité croisée
- Souris, Rat
-
Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogène
- Synthesized peptide derived from the C-terminal region of Human ACBP.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- Diazepam Binding Inhibitor (DBI)
-
Autre désignation
- DBI
-
Sujet
- ACBD 1 antibody, ACBD1 antibody, ACBP antibody, ACBP_HUMAN antibody, Acyl CoA binding domain containing 1 antibody, Acyl CoA binding protein antibody, Acyl Coenzyme A binding domain containing 1 antibody, Acyl coenzyme A binding protein antibody, Acyl-CoA-binding protein antibody, CCK RP antibody, CCKRP antibody, Cholecystokinin releasing peptide trypsin sensitive antibody, DBI antibody, Diazepam-binding inhibitor antibody, Endozepine antibody, EP antibody, GABA receptor modulator antibody, MGC70414 antibody
-
UniProt
- P07108
Antigène
-